In the future, some Linux subsystems will only be written in Rust. Rust is much safer than C, but it's no silver bullet for ...

Do we love Yoruichi? For the two new Universal Tower Defense codes named after them, yes. Yes we do. July 6, 2026: While the devs say "dont use the code guys, respect the ogs," we say use the new ...

We at WIRED know that one of the best ways to save on essential (often price) tech is buying through a trusted retailer like Newegg, and that’s why we have a WIRED-exclusive promo code, valid only on ...

1st July 2026: We added new Steal The Brainrot codes. If you've played another astoundingly popular Brainrot game bearing a similar title, you'll probably feel right at home playing Fortnite creator ...

There is no feeling better than riding a dragon into action, or was it a mythical lion? Mount RNG fulfills the desire of every kid to ride mythical and anime beasts as mounts. But like with all Roblox ...

Hoping to get some new goodies to take down enemies in style in RIVALS? We’re here to help. Below, we’ve collected all the active RIVALS codes currently available for Roblox’s popular first-person ...

A new study of bilingual speakers suggests that a single “grammatical engine” in the brain can power multiple languages at once. By K. R. Callaway Speak a language your whole life and its grammatical ...

Toyota has matured its EV lineup with the new bZ, bZ Woodland, and C-HR. We compare their range, power, and price to help you choose the best Toyota EV for you. Toyota’s new EV lineup includes the bZ, ...

A security researcher has released exploit code for a Visual Studio Code (VS Code) zero-day vulnerability that allows attackers to steal GitHub authentication tokens by tricking users into clicking a ...

I’ve been a travel editor for almost a decade now, so to say I’ve experienced my fair share of hotels would be an understatement. I’ve stayed in five-star estates in South Africa, beach shacks in ...

Patient reported outcomes (PRO) during and after multimodal treatment for resectable esophageal adenocarcinoma in the prospective, randomized, controlled, multicenter phase III ESOPEC trial.